ENHANCEMENT OF MORPHINE ANALGESIA BY THE GABA(B) AGONIST BACLOFEN

被引:87
作者
GORDON, NC
GEAR, RW
HELLER, PH
PAUL, S
MIASKOWSKI, C
LEVINE, JD
机构
[1] UNIV CALIF SAN FRANCISCO, DEPT ORAL & MAXILLOFACIAL SURG, DIV RHEUMATOL, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF SAN FRANCISCO, GRAD PROGRAM ORAL BIOL, SAN FRANCISCO, CA 94143 USA
[3] UNIV CALIF SAN FRANCISCO, GRAD PROGRAM NEUROSCI, SAN FRANCISCO, CA 94143 USA
[4] UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL NURSING, SAN FRANCISCO, CA 94143 USA
[5] UNIV CALIF SAN FRANCISCO, DEPT EPIDEMIOL & BIOSTAT, SAN FRANCISCO, CA 94143 USA
[6] UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA
[7] UNIV CALIF SAN FRANCISCO, DEPT ANAT, SAN FRANCISCO, CA 94143 USA
[8] KAISER FDN HOSP, HAYWARD, CA 94545 USA
关键词
GENDER; PENTAZOCINE; KAPPA-OPIOID; MU-OPIOID; DENTAL PAIN;
D O I
10.1016/0306-4522(95)00335-G
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Opioid-GABAergic interactions for the treatment of post-operative pain were investigated in two double-blind, placebo-controlled experiments. We first studied the effect of pre-operatively administered baclofen, a GABA(B) receptor agonist, on the analgesia produced by intravenously administered morphine, a predominantly mu-opioid analgesic. In a separate trial, we studied the effect of baclofen on the analgesia produced by pentazocine, a predominantly kappa-opioid analgesic. While baclofen alone did not affect the level of post-operative pain, morphine analgesia was significantly enhanced by baclofen compared to placebo. In contrast, baclofen did not affect the level of pentazocine analgesia: however, females receiving pentazocine showed significantly greater analgesia than males.
引用
收藏
页码:345 / 349
页数:5
相关论文
共 44 条
[1]  
BAUMANN PA, 1990, N-S ARCH PHARMACOL, V341, P88
[2]   TIME-RELATED DECREASES IN MU AND DELTA OPIOID RECEPTORS IN THE SUPERFICIAL DORSAL HORN OF THE RAT SPINAL-CORD FOLLOWING A LARGE UNILATERAL DORSAL RHIZOTOMY [J].
BESSE, D ;
LOMBARD, MC ;
BESSON, JM .
BRAIN RESEARCH, 1992, 578 (1-2) :115-121
[3]   GABA-B RECEPTOR PHARMACOLOGY [J].
BOWERY, NG .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1993, 33 :109-147
[4]  
BOWERY NG, 1992, ARZNEIMITTELFORSCH, V42-1, P215
[5]  
CAPEK R, 1982, CAN J PHYSIOL PHARM, V60, P160
[6]  
CEDARBAUM J M, 1990, P463
[7]  
CORLI O, 1984, CLIN THER, V6, P800
[8]   BACLOFEN FOR THE TREATMENT OF ACUTE LOW-BACK SYNDROME - A DOUBLE-BLIND COMPARISON WITH PLACEBO [J].
DAPAS, F ;
HARTMAN, SF ;
MARTINEZ, L ;
NORTHRUP, BE ;
NUSSDORF, RT ;
SILBERMAN, HM ;
GROSS, H .
SPINE, 1985, 10 (04) :345-349
[9]   EFFECTS OF TOPICAL BACLOFEN ON C FIBER-EVOKED NEURONAL-ACTIVITY IN THE RAT DORSAL HORN [J].
DICKENSON, AH ;
BREWER, CM ;
HAYES, NA .
NEUROSCIENCE, 1985, 14 (02) :557-562
[10]   DIFFERENCES IN POSTOPERATIVE PAIN SEVERITY AMONG 4 ETHNIC-GROUPS [J].
FAUCETT, J ;
GORDON, N ;
LEVINE, J .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1994, 9 (06) :383-389